Clinical Trial Update: A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Contrave for weight recidivism after bariatric surgery in obesity patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CONTRAVE (bupropion/naltrexone)

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Obesity | Phase 4 | Status: UNKNOWN